Retinopathy of Prematurity
125
11
14
74
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
13 trials with published results (10%)
Research Maturity
74 completed trials (59% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.4%
8 terminated out of 125 trials
90.2%
+3.7% vs benchmark
17%
21 trials in Phase 3/4
18%
13 of 74 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 74 completed trials
Clinical Trials (125)
Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity
Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants
An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)
A Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blood Vessels Grow Abnormally in the Retina (Retinopathy of Prematurity)
Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)
Bevacizumab Treatment For Type 1 ROP
Study of the Implication of Omega-3 Polyunsaturated Fatty Acids in Retinopathy of Prematurity in New-born Infants
Automated Screening Device to Detect MTMROP
Validation of i-ROP DL to Detect More Than Mild ROP
Iron and Retinopathy of Prematurity (ROP)
Imaging Retinal Vasculature in Infant Eyes
Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)
Regulatory PMS Study for Lucentis® in Patients With Retinopathy of Prematurity
Comfort Level in Premature Infants Undergoing Retinopathy of Prematurity Screening
A 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Participants in China
Efficacy and Safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening
umBilical Or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity (BORN)
Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity
Improve Screening Criteria for Retinopathy of Prematurity in Two French Center
Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study